Blog
RSS FeedPosted by Michael Wonder on 29 Sep 2022
Why non-funding of cystic fibrosis treatment is unacceptable
30 September 2022 - Edward Lee has self-funded the Trikafta drug that alleviates the symptoms of his cystic fibrosis since 2019. ...
Posted by Michael Wonder on 29 Sep 2022
Auckland toddler may be able to dance again after PHARMAC proposes funding drug
29 September 2022 - An Auckland toddler who was losing the ability to walk may be able to dance again, ...
Posted by Michael Wonder on 27 Sep 2022
More medicines for New Zealanders, thanks to Government’s Budget boost
28 September 2022 - Health Minister Andrew Little is welcoming news that two more important medicines are set to be ...
Posted by Michael Wonder on 27 Sep 2022
PHARMAC seeking feedback on nusinersen sodium and adrenaline auto-injectors funding
28 September 2022 - PHARMAC has initiated two consultations today, seeking feedback on the funding of two different medicines that we've ...
Posted by Michael Wonder on 25 Sep 2022
My brother is dying while there's a drug that could stop this
26 September 2022 - PHARMAC announced on Friday last week that Trikafta, a potentially life-saving drug for those suffering with ...
Posted by Michael Wonder on 25 Sep 2022
Blurring boundaries: how Jacinda Ardern challenges journalism’s ethics
21 September 2022 - Everyone who cares about the current situation regarding timely access to new medicines in New Zealand ...
Posted by Michael Wonder on 24 Sep 2022
Prostate cancer: Tauranga man spends $212,000 on treatment
24 September 2022 - Five thousand and five hundred dollars every 28 days - more than $200,000 so far. ...
Posted by Michael Wonder on 22 Sep 2022
PHARMAC plans switch back to broader pneumococcal vaccine, following surge in deadly disease cases
21 September 2022 - PHARMAC plans to give all babies access to a broader pneumococcal vaccine from December, after a ...
Posted by Michael Wonder on 19 Sep 2022
PHARMAC considering multiple new treatments from Takeda
19 September 2022 - Pharmac has initiated consultation today on a provisional bundle deal with Takeda to fund vedolizumab for people ...
Posted by Michael Wonder on 16 Sep 2022
PHARMAC can't progress cystic fibrosis drug Trikafta - CF New Zealand
16 September 2022 - PHARMAC is not in a position to progress funding on the life-extending cystic fibrosis drug, Trikafta, ...
Posted by Michael Wonder on 15 Sep 2022
Can the proposed listing of two medicines from the same supplier really be called a bundle deal?
16 September 2022 - On Wednesday, PHARMAC announced a "medicines bundle to provide more treatment options for New Zealanders." ...
Posted by Michael Wonder on 15 Sep 2022
Advocates welcome PHARMAC's removal of barriers to menopausal symptoms treatment
15 September 2022 - A women's health expert says today marks a major win for wāhine in Aotearoa, with PHARMAC ...
Posted by Michael Wonder on 15 Sep 2022
Progesterone to be fully funded for all who need it
15 September 2022 - PHARMAC has today confirmed that it is removing all funding restrictions from progesterone, with tens of thousands ...
Posted by Michael Wonder on 14 Sep 2022
PHARMAC announces medicines bundle to provide more treatment options for New Zealanders
14 September 2022 - PHARMAC is considering funding two medicines as part of a new bundle agreement that would offer ...
Posted by Michael Wonder on 13 Sep 2022
Family of baby spending first birthday in hospital with pneumococcal complications calls for vaccine switch
13 September 2022 - At first, doctors thought it was a common virus. Baby Eloise Swadel had a cough and ...